This Champion of Community’s Role in Clinical Trials Reflects on 40 Years of Fighting Medical Mistrust And Research Neglect
Wakefield retires from the HIV Vaccine Trials Network after 20 years of service.
In addition to scientific advances, the 23rd International AIDS Conference also focused on the human rights of marginalized groups.
Will We Ever Have a Hepatitis C Vaccine? Two Activists Weigh in on the Challenges and Opportunities Ahead
A new injection of funding from Congress could be the catalyst for a future hepatitis C (HCV) vaccine.
Your former and current Black employees often swap battle stories in private.
April 9, 2020: Rapid efficacy of integrase-based treatment; a potent PrEP ad campaign in Chicago; more frequent STI screening for PrEP users; Ryan White funding fuels critical rural HIV care and services.
Advocates and public health organizations say the 2015 policy revision still stigmatizes gay men and isn’t based on science.
Want to Hire More Transgender and Gender Nonconforming Folks at Your Agency? These Staffers Have Some Blunt Advice
Many HIV service organizations say they’re open to hiring TGNC employees, but advocates say most have a long way to go.
Advocate D. Rashaan Gilmore explains how white-led HIV organizations in the U.S. engage in movement capture—e.g., the co-opting of Black racial justice efforts—under the guise of ending the HIV epidemic.
Even after a series of reforms in 2015, advocates say U.S. policy still discriminates and furthers HIV stigma. Anthony Santella, Dr.P.H., M.P.H., has a better idea.
Asa Radix, M.D., M.P.H., discusses providing quality care to transgender people. It can be done.